About: Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.42 (+4.00%)
DYAI NASDAQ Dyadic International Inc
Dyadic International Inc share price
Atividade de preço de DYAI
Último preço
$ 0,430
Variação (24h)
0,03 USD (7,48%)
Volume
55.50K
Volume (média 4 sem.)
-
Abertura
$ 0,40
Variação do dia
$ 0,40 - $ 0,47
Fechamento anterior
$ 0,40
Último negócio
26 Oct, 4:51 pm GMT+0
Atrasado
26 Oct, 4:51 pm GMT+0
DYAI price performance
Atrasado
26 Oct, 4:51 pm GMT+0
quote.marketSignals